Skip to content

Trifecta-Lung cfDNA-MMDx Study

Lung Transplantation

Demonstrate the relationship between dd-cfDNA levels and HLA antibodies in blood transplant recipient and Demonstrate the Molecular Microscope® (MMDx) Diagnostic System results in indication and protocol biopsies from lung transplants.

null

Participation Requirements

  • Sex:

    ALL

  • Eligible Ages:

    18 and up

Participation Criteria

Inclusion Criteria:

Adult, Older adult

Exclusion Criteria:

Patients will be excluded from the study if they decline participation Are unable to give informed consent. Recipients of multiple organs, cancer patients and pregnant women

Study Location

University Health Network, Toronto General Hospital
University Health Network, Toronto General Hospital
Toronto, Ontario
Canada

Contact Study Team

Primary Contact

Shaf Keshavjee, MD MSc

[email protected]
1 416-340-3863
Alberta Transplant Applied Genomics Centre, University of Alberta
Alberta Transplant Applied Genomics Centre, University of Alberta
Edmonton, Alberta
Canada

Contact Study Team

Primary Contact

Konrad S Famulski, PhD DSc

[email protected]
1 7807829463
Backup Contact

Robert Polakowski, PhD

[email protected]
1 7804925091
Department of Medicine, University of Alberta
Department of Medicine, University of Alberta
Edmonton, Alberta
Canada

Contact Study Team

Primary Contact

Kieran Halloran, MD MSC

[email protected]
1 780 492 2691
Study Sponsored By
University of Alberta
Participants Required
More Information
Study ID: NCT05837663